SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130365
Filing Date
2023-05-01
Accepted
2023-05-01 16:02:12
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d491511d10ka.htm   iXBRL 10-K/A 355248
2 EX-31.3 d491511dex313.htm EX-31.3 3751
3 EX-31.4 d491511dex314.htm EX-31.4 3750
  Complete submission text file 0001193125-23-130365.txt   601287

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA toca-20221231.xsd EX-101.SCH 4967
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20221231_cal.xml EX-101.CAL 669
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20221231_def.xml EX-101.DEF 1674
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20221231_lab.xml EX-101.LAB 21520
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20221231_pre.xml EX-101.PRE 16725
10 EXTRACTED XBRL INSTANCE DOCUMENT d491511d10ka_htm.xml XML 9607
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38052 | Film No.: 23873456
SIC: 2834 Pharmaceutical Preparations